On Friday, the pharmacy institution "Montefarm" announced an annual tender for the procurement of ampoule medicines, which is worth around 28 million euros.
"Montefarm", and for the needs of health institutions, needs 317 different medicines, among which are solutions for infusion, injections, powders, biological medicines, cytostatics for cancer treatment...
Among the drugs for which the most money will be allocated individually are bevacizumab, a biological drug concentrate for solution for infusion, which is used in hospitals against colon cancer. "Montefarm requested 1.150 doses of medicine, estimated value of around 1.213.000 euros.
Iopromide solution for infusion, whose estimated value is more than one million euros, is also on the list of requested drugs.
Interested suppliers of medicines can submit bids until January 21, while the decision on the most favorable choice will be made within 60 days from that day.
Bidders must meet the mandatory requirements - that they are registered in the register of business entities, properly fulfill their tax obligations, and that they have not been convicted of any of the criminal offenses of organized crime, with elements of corruption, money laundering and fraud.
According to the public procurement plan for the next year, "Montefarm" will spend 58.695.533 euros on works, goods and services.
About 80.000 euros of that sum will go to construction works, i.e. construction of buildings, which will be financed from their own funds.
They should spend 4.000 euros to purchase a truck, office supplies will cost 25.800. The rest of the money will be spent on the purchase of medicines and medical equipment.
Bonus video:
